TN-401
TN-401-0012
Phase 1 gene_therapy active
Quick answer
TN-401 for Arrhythmogenic Right Ventricular Cardiomyopathy is a Phase 1 program (gene_therapy) at Tenaya Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tenaya Therapeutics
- Indication
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active